Guest: David M. Simpson, MD

Find the full Prescribing Information here.

Here to walk us through the clinical trial data that led to the FDA approval of a treatment option for painful diabetic peripheral neuropathy of the feet is Dr. David M. Simpson, a Professor of Neurology at the Icahn School of Medicine and Director of the Clinical Neurophysiology Laboratories and Neuromuscular Division at Mount Sinai in New York.

QUTENZA® is a registered trademark of Averitas Pharma, Inc.©
2021 Averitas Pharma, Inc. All rights reserved.
M-QZA-US-05-21-0006 May 2021